DOCSLIB.ORG

Critical Role of Oxidative Stress in Estrogen-Induced Carcinogenesis

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Critical Role of Oxidative Stress in Estrogen-Induced Carcinogenesis Critical role of oxidative stress in estrogen-induced carcinogenesis Hari K. Bhat*†, Gloria Calaf‡, Tom K. Hei*‡, Theresa Loya§, and Jaydutt V. Vadgama¶ *Department of Environmental Health Sciences, Mailman School of Public Health, 60 Haven Avenue-B1, Columbia University, New York, NY 10032; ‡Center for Radiological Research, Columbia University, New York, NY 10032; and Departments of §Pathology and ¶Medicine, Charles Drew University, Los Angeles, CA 90059 Communicated by Donald C. Malins, Pacific Northwest Research Institute, Seattle, WA, December 27, 2002 (received for review August 22, 2002) Mechanisms of estrogen-induced tumorigenesis in the target quinones generates oxidative stress and potentially harmful free organ are not well understood. It has been suggested that oxida- radicals that are postulated to be required for the carcinogenic tive stress resulting from metabolic activation of carcinogenic process, and analogous to the metabolic activation of hydrocar- estrogens plays a critical role in estrogen-induced carcinogenesis. bons and other nonsteroidal estrogen carcinogens (9, 19–22). We We tested this hypothesis by using an estrogen-induced hamster have investigated the role of oxidative stress in estrogen carci- renal tumor model, a well established animal model of hormonal nogenesis by using a well established hamster renal tumor model carcinogenesis. Hamsters were implanted with 17␤-estradiol (␤E2), that shares several characteristics with human breast and uterine 17␣-estradiol (␣E2), 17␣-ethinylestradiol (␣EE), menadione, a com- cancers, pointing to a common mechanistic origin (6, 9, 23). bination of ␣E2 and ␣EE, or a combination of ␣EE and menadione Different estrogens used in the present study differ in their for 7 months. The group treated with ␤E2 developed target organ estrogenic, carcinogenic, and metabolic activation potentials specific kidney tumors. The kidneys of hamsters treated with ␣E2, (14–17). ␤E2 is a good catechol progenitor and a potent ␣EE, or menadione alone did not show any gross evidence of estrogen; its use results in 80–100% tumor incidence in the tumor. Kidneys of hamsters treated with a combination of ␣E2 and hamster kidney (6, 10, 14, 15). 17␣-estradiol (␣E2) is a nontu- ␣EE showed early signs of proliferation in the interstitial cells. morigenic, weak estrogen with a catechol-forming potential Kidneys of hamsters treated with a combination of menadione and similar to that of ␤E2 (24, 25). 17␣-Ethinylestradiol (␣EE) is a ␣EE showed foci of tumor with congested tubules and atrophic potent estrogen, but a weak catechol progenitor that is either glomeruli. ␤E2-treated tumor-bearing kidneys showed >2-fold nontumorigenic or very weakly tumorigenic in the hamster Ͼ increase in 8-iso-prostaglandin F2␣ (8-iso-PGF2␣) levels compared model with 9 months of continuous exposure required for less with untreated controls. Kidneys of hamsters treated with a than 10% tumor incidence (15, 17). Menadione (2-methyl-1,4- combination of menadione and ␣EE showed increased 8-iso-PGF2␣ napthaquinone) is used in the present study as a model com- levels compared with untreated controls, whereas no increase in pound with known oxidant stress potential to study the influence 8-iso-PGF2␣ was detected in kidneys of ␣EE-treated group. A of oxidative stress on estrogen-induced carcinogenesis (26–28). chemical known to produce oxidative stress or a potent estrogen We used a combination of an oxidant chemical menadione and with poor ability to produce oxidative stress, were nontumorigenic a noncarcinogenic estrogen ␣EE to show the induction of renal in hamsters, when given as single agents, but induced renal tumors, tumors in a rodent model of hormonal carcinogenesis. We also when given together. Thus, these data provide evidence that oxidant demonstrated increased levels of 8-iso-prostaglandin F2␣ (8-iso- ␤ stress plays a crucial role in estrogen-induced carcinogenesis. PGF2␣), a known marker of oxidant stress (29, 30), in E2- induced tumor-bearing kidneys as well as in menadione plus tumor ͉ hormonal carcinogenesis ͉ menadione ͉ prostaglandin ͉ metabolic ␣EE-treated kidneys of hamsters. Our studies suggest that activation oxidative stress plays a critical role in estrogen-induced carcinogenesis. ex hormones are implicated in the development of a variety Materials and Methods of human cancers (1–4). Estrogen administration to post- S Treatment of Animals. Male Syrian hamsters (4–6 weeks old; menopausal women is associated with an increased risk of Harlan Sprague–Dawley, Madison, WI) were housed in our endometrial and breast cancer (1–4). An increasing evidence of animal facility with Purina rodent chow and water available ad elevated breast cancer risk with increases in total lifetime libitum throughout the experiment. Hamsters were implanted exposure of women to estrogens has been presented (1–3). s.c. with 25-mg pellets of ␤E2, ␣E2, ␣EE, menadione, a com- Recently, the clinical trial of estrogen plus progestin treatment bination of ␣E2 ϩ ␣EE, or a combination of ␣EE ϩ menadione. therapy was stopped because of an increased risk of breast cancer These hamsters received a second estrogen or menadione pellet (5). Knowledge of how estrogens induce proliferation and tu- 3 months after initial treatment. Before implantation of the drug morigenesis in their target organ is not well defined (6–9). The pellets, hamsters were anesthetized with a combination of ket- mechanism of tumor induction by estrogens is being investigated amine and xylazine (ketamine, 100 mg͞kg body weight, i.p., and in rodent models of hormonal carcinogenesis. The natural ͞ ␤ ␤ xylazine, 10 mg kg body weight, i.p.). Estrogen and menadione female sex hormone 17 -estradiol ( E2) and the synthetic pellets were prepared by using a hand press and implanted into estrogen diethylstilbestrol induce tumors in rats, mice, and the hamsters s.c. as described (10, 12). There were 10 hamsters hamsters (10–13). It must be noted that in rodent models, in each group. A control group of 10 animals was sham operated different estrogens tested have not shown similar carcinogenic and left untreated. Hamsters were killed after 7 months and potential despite their similar hormonal potencies (6, 14, 15). inspected macroscopically for tumor nodules on the surface of However, carcinogenic and noncarcinogenic estrogens differ in each kidney as reported (31). Portions of liver and kidney tissue their metabolic activation profiles (14–17). Therefore, it is were placed on dry ice and stored at Ϫ80°C for further studies. postulated that estrogen metabolism may play a key role in hormonal carcinogenesis. Estrogens can be metabolically activated into catechol estro- Abbreviations: ␤E2, 17␤-estradiol; ␣E2, 17␣-estradiol; ␣EE, 17␣-ethinylestradiol; ER, estro- gens by cytochrome P450 enzymes (18, 19). Metabolic redox gen receptor; 8-iso-PGF2␣, 8-iso-prostaglandin F2␣. BIOCHEMISTRY cycling between catechol estrogens and their corresponding †To whom correspondence should be addressed. E-mail: [email protected]. www.pnas.org͞cgi͞doi͞10.1073͞pnas.0437929100 PNAS ͉ April 1, 2003 ͉ vol. 100 ͉ no. 7 ͉ 3913–3918 Downloaded by guest on September 26, 2021 Other portions of liver and kidney were placed in 10% buffered wt͞vol) were prepared by using a PRO 200 homogenizer with a formalin for histopathological evaluation and immunocytochem- 5mmϫ 75 mm generator (PRO Scientific, Oxford, CT) in 2-ml ical studies. Menadione and all estrogens used in the present microfuge tubes. Homogenization was carried out by moving the study were purchased from Sigma. motor speed dial of the homogenizer from 0 to 5 (0–30,000 rpm) back and forth five times with a total homogenization time of Ϸ ␮ Tissue Preparation for Histopathology and Immunocytochemistry. 5 s. 8-iso-PGF2␣ esters in 100 l of the total kidney homoge- The formalin-fixed tissue was embedded in paraffin, and sections nate were hydrolyzed by incubation with 25 ␮lof10N NaOH at of 4- to 5-␮m thickness were cut. Paraffin-embedded sections of 45°C for 2 h. The reaction mixture was cooled on ice for 5 min the kidneys and livers were stained with hematoxylin and eosin and neutralized with 25 ␮l of 12 N HCl, and centrifuged in a for histopathological evaluation. Gross examination and histo- microcentrifuge for 5 min. The clear neutralized supernatant was logical sections were interpreted by two independent patholo- transferred into a new microfuge tube, and 50 ␮l of the neu- gists in a blinded fashion, without knowledge as to how the tralized sample was used for 8-iso-PGF2␣ assay. The samples animals were stratified. Paraffin-embedded sections were also were incubated with the 8-iso-PGF2␣ antibody for 18 h at 4°Cin used for cell-specific expression of estrogen receptor (ER)-␣ and a 96-well format. After incubation, the contents of the wells were -␤ proteins. Deparaffinized sections were incubated with the emptied and washed with wash buffer; wash buffer was removed corresponding primary antibodies: ER-␣ (Santa Cruz Biotech- from the wells, and the color was developed by incubation with nology, SC-542) and ER-␤ (Santa Cruz Biotechnology, SC-6821) 200 ␮lofp-nitrophenyl phosphate for 45 min at room temper- at dilutions suggested by the suppliers. Incubation with the ature. The reaction was stopped by the addition of 50 ␮l of stop primary antibodies was performed overnight at 4°C. Nonspecific solution, and the plate was read at 405 nm. A standard curve was sites were blocked by covering sections with solutions of 1% BSA generated by measuring the optical density of 160–100,000 ͞ (Sigma). After washing in PBS, the sections were incubated with pg ml of 8-iso-PGF2␣ standards that were processed simulta- Ј peroxidase-conjugated, affinity-purified F(ab )2 fragment of neously with unknown samples on the same plate. Protein donkey anti-rabbit IgG (Jackson ImmunoResearch) for 60 min concentrations from the neutralized homogenates were deter- at room temperature as described (12). Slides were rinsed three mined by using a Pierce protein assay kit.
Load more

Recommended publications
  • Cryptorchidism and Endocrine Disrupting Chemicals ⇑ Helena E
    Molecular and Cellular Endocrinology 355 (2012) 208–220 Contents lists available at SciVerse ScienceDirect Molecular and Cellular Endocrinology journal homepage: www.elsevier.com/locate/mce Review Cryptorchidism and endocrine disrupting chemicals ⇑ Helena E. Virtanen , Annika Adamsson Department of Physiology, University of Turku, Finland article info abstract Article history: Prospective clinical studies have suggested that the rate of congenital cryptorchidism has increased since Available online 25 November 2011 the 1950s. It has been hypothesized that this may be related to environmental factors. Testicular descent occurs in two phases controlled by Leydig cell-derived hormones insulin-like peptide 3 (INSL3) and tes- Keywords: tosterone. Disorders in fetal androgen production/action or suppression of Insl3 are mechanisms causing Cryptorchidism cryptorchidism in rodents. In humans, prenatal exposure to potent estrogen diethylstilbestrol (DES) has Testis been associated with increased risk of cryptorchidism. In addition, epidemiological studies have sug- Endocrine disrupting chemical gested that exposure to pesticides may also be associated with cryptorchidism. Some case–control stud- ies analyzing environmental chemical levels in maternal breast milk samples have reported associations between cryptorchidism and chemical levels. Furthermore, it has been suggested that exposure levels of some chemicals may be associated with infant reproductive hormone levels. Ó 2011 Elsevier Ireland Ltd. All rights reserved. Contents 1. Background.
    [Show full text]
  • Pp375-430-Annex 1.Qxd
    ANNEX 1 CHEMICAL AND PHYSICAL DATA ON COMPOUNDS USED IN COMBINED ESTROGEN–PROGESTOGEN CONTRACEPTIVES AND HORMONAL MENOPAUSAL THERAPY Annex 1 describes the chemical and physical data, technical products, trends in produc- tion by region and uses of estrogens and progestogens in combined estrogen–progestogen contraceptives and hormonal menopausal therapy. Estrogens and progestogens are listed separately in alphabetical order. Trade names for these compounds alone and in combination are given in Annexes 2–4. Sales are listed according to the regions designated by WHO. These are: Africa: Algeria, Angola, Benin, Botswana, Burkina Faso, Burundi, Cameroon, Cape Verde, Central African Republic, Chad, Comoros, Congo, Côte d'Ivoire, Democratic Republic of the Congo, Equatorial Guinea, Eritrea, Ethiopia, Gabon, Gambia, Ghana, Guinea, Guinea-Bissau, Kenya, Lesotho, Liberia, Madagascar, Malawi, Mali, Mauritania, Mauritius, Mozambique, Namibia, Niger, Nigeria, Rwanda, Sao Tome and Principe, Senegal, Seychelles, Sierra Leone, South Africa, Swaziland, Togo, Uganda, United Republic of Tanzania, Zambia and Zimbabwe America (North): Canada, Central America (Antigua and Barbuda, Bahamas, Barbados, Belize, Costa Rica, Cuba, Dominica, El Salvador, Grenada, Guatemala, Haiti, Honduras, Jamaica, Mexico, Nicaragua, Panama, Puerto Rico, Saint Kitts and Nevis, Saint Lucia, Saint Vincent and the Grenadines, Suriname, Trinidad and Tobago), United States of America America (South): Argentina, Bolivia, Brazil, Chile, Colombia, Dominican Republic, Ecuador, Guyana, Paraguay,
    [Show full text]
  • Estrogen Actions Throughout the Brain
    Estrogen Actions Throughout the Brain BRUCE MCEWEN Harold and Margaret Milliken Hatch Laboratory of Neuroendocrinology, The Rockefeller University, New York, New York 10021 ABSTRACT Besides affecting the hypothalamus and other brain areas related to reproduction, ovarian steroids have widespread effects throughout the brain, on serotonin pathways, catecholaminergic neurons, and the basal forebrain cholinergic system as well as the hippocampal formation, a brain region involved in spatial and declarative memory. Thus, ovarian steroids have measurable effects on affective state as well as cognition, with implications for dementia. Two actions are discussed in this review; both appear to involve a combination of genomic and nongenomic actions of ovarian hormones. First, regulation of the serotonergic system appears to be linked to the presence of estrogen- and progestin-sensitive neurons in the midbrain raphe as well as possibly nongenomic actions in brain areas to which serotonin neurons project their axons. Second, ovarian hormones regulate synapse turnover in the CA1 region of the hippocampus during the 4- to 5-day estrous cycle of the female rat. Formation of new excitatory synapses is induced by estradiol and involves N-methyl-D-aspartate (NMDA) receptors, whereas downregulation of these synapses involves intracellular progestin receptors. A new, rapid method of radioimmunocytochemistry has made possible the demonstration of synapse formation by labeling and quantifying the specific synaptic and dendritic molecules involved. Although NMDA receptor activation is required for synapse formation, inhibitory interneurons may play a pivotal role as they express nuclear estrogen receptor-alpha (ER␣). It is also likely that estrogens may locally regulate events at the sites of synaptic contact in the excitatory pyramidal neurons where the synapses form.
    [Show full text]
  • Interactions of Putative Estrogens with the Intracellular Receptor Complex in Mouse Leydig Cells: Relationship to Preneoplastic Hyperplasia R
    [CANCER RESEARCH 48, 14-18, January 1, 1988) Interactions of Putative Estrogens with the Intracellular Receptor Complex in Mouse Leydig Cells: Relationship to Preneoplastic Hyperplasia R. Lloyd Juriansz,1 Robert A. Huseby, and R. Bruce Wilcox2 Department of Biochemistry, Loma Linda University, Loma Linda, California 92350 ABSTRACT (3), the initial spurt of DNA synthesis occurs independent of pituitary function (6). Actual tumor induction, however, results The interaction of 14 steroidal and nonsteroidal estrogen agonists and from action of unmetabolized estrogen directly upon the Leydig antagonists with the intracellular estrogen receptor system was examined cells (7). These cells in both a susceptible and a nonsusceptible in cell suspensions prepared from the testes of mice that develop malig strain of mouse contain an ER3 complex. The cells from the nant Leydig cell tumors after prolonged estrogen administration. The ability of these substances to stimulate DNA synthesis in short-term (3- two strains differ significantly in that nuclei from susceptible day) studies and to provoke Leydig cell hyperplasia with prolonged (3- animals bind more estrogen, and the proportion of the nuclear mo) administration was also measured. Our data were consistent with ER that remains fixed to the nuclear matrix in solutions of the proposal that, in Leydig cells, the carcinogenic effects of estrogens high salt concentration is greater in the tumor-susceptible ani are mediated through the intracellular receptor complex that results in a mals (8). Furthermore this fraction of the ER increases in localization of hormone bound to chromâtin and nuclear matrix. All tested compounds displaced 170-[3H]estradiol from the cytosolic amount per Leydig cell as estrogen treatment of susceptible mice continues over a 3-mo period and hyperplasia is initiated estrogen receptor, but to varying degrees; and there was no discernible (9).
    [Show full text]
  • Identification and Confirmation of the Environmental Risks of Emerging Pollutants in Surface Waters and Sediments
    Identification and confirmation of the environmental risks of emerging pollutants in surface waters and sediments Von der Fakultät für Mathematik, Informatik und Naturwissenschaften der RWTH Aachen University zur Erlangung des akademischen Grades eines Doktors der Naturwissenschaften genehmigte Dissertation Vorgelegt von Shangbo Zhou, Master of engineering aus Gansu, China Berichter: Univ.-Prof. Dr. rer. nat. Henner Hollert Univ.-Prof. Dr. rer. nat. Andreas Schäffer Tag der mündlichen Prüfung: 24.09.2019 Diese Dissertation ist auf den Internetseiten der Universitätsbibliothek online verfügbar. Your teacher can open the door but you must enter by yourself. – Chinese verb Abstract Although the occurrence, the fate and the toxicology of emerging pollutants in the aquatic environment have been widely studied, there is still a lack in the correlation of the levels of pollutants with the possible adverse effects in wildlife. The shortcomings of traditional methods for risk assessment have been observed, and the contributions of the identified compounds to the observed risks are rarely confirmed. Therefore, the main purpose of this thesis was to develop reasonable methods for risk identification of single compounds and mixtures, and to identify and confirm environmental risks caused by non-specific and mechanism-specific toxicity in aquatic systems. In this thesis, optimized methods for risk identification of single compounds and mixtures were developed. For screening-level risk assessment of single compounds, an optimized risk quotient that considers not only toxicological data but also the frequency with which the detected concentrations exceeded predicted no-effect concentrations was used to screen candidate priority pollutants in European surface waters. Results showed that 45 of the 477 analyzed compounds indicated potential risks for European surface waters.
    [Show full text]
  • Effects of Diethylstilbestrol on the Proliferation and Tyrosinase Activity of Cultured Human Melanocytes
    BIOMEDICAL REPORTS 3: 499-502, 2015 Effects of diethylstilbestrol on the proliferation and tyrosinase activity of cultured human melanocytes JIANBING TANG, QIN LI, BIAO CHENG, CHONG HUANG and KUI CHEN Department of Plastic Surgery, The Key Laboratory of Trauma Treatment and Tissue Repair of Tropical Area, People's Liberation Army, HuaBo BioPharmaceutical Institute of Guangzhou, General Hospital of Guangzhou Military Command, Guangzhou, Guangdong 510010, P.R. China Received March 13, 2015; Accepted April 24, 2015 DOI: 10.3892/br.2015.472 Abstract. The aim of the present study was to observe the with estrogen. The pigmented spot becomes more severe and effects of different exogenous estrogen diethylstilbestrol (DES) malignant melanoma proceeds rapidly during an abnormal concentrations on the human melanocyte proliferation and menstruation or pregnancy. There are changes in the estrogen tyrosinase activity. Skin specimens were obtained following level in these physiological processes. Therefore, estrogen blepharoplasty, and the melanocytes were primary cultured is considered an important factor that affects pigmented and passaged to the third generation. The melanocytes were diseases (1). Diethylstilbestrol (DES) is a synthetic nonsteroidal seeded in 96-well plates, each well had 5x103 cells. The medium estrogen that can produce the same pharmacological effects as was changed after 24 h, and contained 10-4-10 -8 M DES. After natural estrogen (2). In order to explore the mechanism, the the melanocytes were incubated, the proliferation and tyrosi- excess skin following eyelid blepharoplasty was collected for nase activity were detected by the MTT assay and L-DOPA melanocyte culture and different DES concentrations were reaction. DES (10-8-10 -6 M) enhanced the proliferation of used to detect the effect on the proliferation and tyrosinase cultured melanocytes.
    [Show full text]
  • Endocrine Disruptors and Their Influence in the Origin of Breast Neoplasm and Other Breast Pathologies
    REVIEW ARTICLE DOI: 10.29289/2594539420180000294 ENDOCRINE DISRUPTORS AND THEIR INFLUENCE IN THE ORIGIN OF BREAST NEOPLASM AND OTHER BREAST PATHOLOGIES Disruptores endócrinos e o seu papel na gênese das neoplasias e de outras patologias das mamas Mauri José Piazza1*, Almir Antônio Urbanetz1, Cicero Urban2 ABSTRACT A higher occurrence of early breast cancer in women has created the need to identify possible etiologic agents characterized as direct co-responsible. The motivation for this review is the relevance of detecting potential endocrine disruptors responsible for harmful effects on breast tissue and, consequently, its damage. KEYWORDS: Breast; breast cancer; breast neoplasms. RESUMO Uma maior ocorrência no surgimento precoce das neoplasias das mamas em mulheres tem gerado a necessidade da descoberta dos possíveis agentes etiológicos caracterizados como corresponsáveis diretos. A relevância da detecção dos possíveis disruptores endócrinos responsáveis por exercer efeitos danosos nos tecidos mamários e, consequentemente, o seu comprometimento é a motivação da presente revisão. PALAVRAS-CHAVE: Mama; câncer de mama; neoplasias da mama. Study conducted at Universidade Federal do Paraná – Curitiba (PR), Brazil. 1Department of Obstetrics and Gynecology, Universidade Federal do Paraná – Curitiba (PR), Brazil. 2Universidade Positivo – Curitiba (PR), Brazil. *Corresponding author: [email protected] Conflict of interests: nothing to declare. Received on: 11/16/2017. Accepted on: 02/05/2018. Mastology, 2018;28(4):257-67 257 Piazza MJ, Urbanetz AA, Urban C INTRODUCTION 2. Phthalates (Figure 2): phthalates and phthalate esters are also In recent decades, a higher incidence of hormone-dependent neo- commonly used in the plastic and toys industries, in cosmet- plasms has been observed in body parts such as breasts, endo- ics, and in medical tubing manufacturing.
    [Show full text]
  • Diethylstilbestrol Lignant Cervical and Vaginal Tumors (Polyps, Squamous-Cell Papilloma, and Myosarcoma) in Female Hamsters, and Benign and Malignant Tes­ CAS No
    Report on Carcinogens, Fourteenth Edition For Table of Contents, see home page: http://ntp.niehs.nih.gov/go/roc Diethylstilbestrol lignant cervical and vaginal tumors (polyps, squamous­cell papilloma, and myosarcoma) in female hamsters, and benign and malignant tes­ CAS No. 56-53-1 ticular tumors (granuloma, adenoma, and leiomyosarcoma) in male hamsters. Prenatal exposure also caused uterine cancer (adenocarci­ Known to be a human carcinogen noma) in female mice and hamsters, benign ovarian tumors (cystad­ First listed in the First Annual Report on Carcinogens (1980) enoma and granulosa­cell tumors) in female mice, and benign lung Also known as DES, diethylstilboestrol, or stilboestrol tumors (papillary adenoma) in mice of both sexes. Prenatal expo­ sure did not cause tumors in monkeys observed for up to six years CH 3 after birth. Mice developed cervical and vaginal tumors after receiv­ H2C ing a single subcutaneous injection of diethylstilbestrol on the first C OH day of life, and male rats developed cancer of the reproductive tract HO C (squamous­cell carcinoma) after receiving daily subcutaneous injec­ CH2 tions for the first month of life. Diethylstilbestrol also caused cancer in experimental animals ex­ H3C Carcinogenicity posed as adults. When administered orally, diethylstilbestrol caused cancer of the mammary gland (carcinoma and adenocarcinoma) in Diethylstilbestrol is known to be a human carcinogen based on suffi­ mice of both sexes and benign mammary­gland tumors (fibroade­ cient evidence of carcinogenicity from studies in humans. noma) in rats of both sexes. In addition, cancer of the cervix and uterus (adenocarcinoma), vagina (squamous­cell carcinoma), and Cancer Studies in Humans bone (osteosarcoma) occurred in mice, and benign and malignant The strongest evidence for carcinogenicity comes from epidemiolog­ pituitary­gland and liver tumors (hepatocellular tumors and heman­ ical studies of women exposed to diethylstilbestrol in utero (“diethyl­ gioendothelioma) occurred in rats.
    [Show full text]
  • Estriol Prevention of Mammary Carcinoma Induced by 7,12-Dimethylbenzanthracene and Procarbazine1
    (CANCER RESEARCH 35, 1341 1353, May 1975] Estriol Prevention of Mammary Carcinoma Induced by 7,12-Dimethylbenzanthracene and Procarbazine1 Henry M. Lemon Section of Oncology, Department of Internal Medicine, The University of Nebraska Medical Center, 42nd Street and Dewey Avenue, Omaha. Nebraska 68105 SUMMARY hexestrol, 0.60 mg/pellet, did not alter breast cancer incidence in 220 additional rats. Estrogen-treated rats The concentration of estrogenic, androgenic, progesta- usually sustained a mean 0.6 to 8.9% reduction of body tional, and adrenocortical steroid hormones in body fluids growth for the first 6 to 8 months of observation; this did of mature intact Sprague-Dawley female rats was increased not correlate with the breast carcinoma-suppressive activi by s.c. implantation of 5 to 7 mg NaCl pellets containing 1 ties of individual steroids. to 20% steroid 48 hr before administration p.o. of either Single implantation of 0.60 mg estriol 48 hr before 7,12-dimethylbenz(a)anthracene or procarbazine. The inci dimethylbenzanthracene p.o. or sustained implantation dence of rats developing one or more mammary carcinomas every 2 months of 10% estriol pellets beginning 24 hr after in each treated group was compared to that observed in si carcinogen exposure failed significantly to alter mammary multaneously treated groups receiving only the carcinogen, carcinoma development after dimethylben/anthracene ad steroid, or no treatment whatsoever, with weekly observa ministration. tion of all rats until palpably growing tumors were biopsied Inhibition of mammary carcinogenesis induced by these and proven carcinomatous or until death occurred from two dissimilar carcinogens in intact mature rats using other causes determined by autopsy.
    [Show full text]
  • Dalton Pharma Catalogue Steroids 12-19-12
    2012/2013 Version: December 31, 2012 Steroid Analytical Reference Standards and Drug Impurities Dalton Pharma Services: A Health Canada Approved Facility Level-8 Controlled Substances License on-site SCC Approved GLP Facility North American Manufactured and Shipped To Order Call: 1.800.567.5060 To Order Call: 416.661.2102 Email: [email protected] Email: [email protected] Page 2 Dalton Standards and Impurities Table of Contents Introduction/Company Profile 4 Custom Synthesis Overview 6 Contract Research/Medicinal Chemistry 7 Process Development Overview 8 Analytical Services 9 GMP API & Sterile Filling Services 11 Formulation Development Overview 12 Liposomes 13 Dalton Standards and Impurities 14 Establishment License 16 Certificate example 17 Steroids 18 Page 3 To Order Call: 1.800.567.5060 To Order Email: [email protected] Call: Company Profile About Dalton Pharma Services Dalton Pharma Services is a privately-held pharmaceutical services company that has been producing Fine Chemi- cals on a custom basis for research and chemical supply houses for over twenty-five years (Fluka, Aldrich, Sigma, Acros). We have identified and supplied many new re- agents for biological and pharmaceutical applications, this includes novel analogues and impurities of active pharma- ceuticals ingredients, as well as new linkers. We are lead- ers in process development, process improvement, and in the field of isolation of kilo quantities of biologically active molecules from natural sources. Dalton excels at advancing projects from R&D into GMP environments for its customers. With the ability to manufacture cGMP API's from bench scales to multi kilos we can meet most clinical and small scale commercial requirements.
    [Show full text]
  • United States Patent (19) 11 Patent Number: 6,068,830 Diamandis Et Al
    US00606883OA United States Patent (19) 11 Patent Number: 6,068,830 Diamandis et al. (45) Date of Patent: May 30, 2000 54) LOCALIZATION AND THERAPY OF FOREIGN PATENT DOCUMENTS NON-PROSTATIC ENDOCRINE CANCER 0217577 4/1987 European Pat. Off.. WITH AGENTS DIRECTED AGAINST 0453082 10/1991 European Pat. Off.. PROSTATE SPECIFIC ANTIGEN WO 92/O1936 2/1992 European Pat. Off.. WO 93/O1831 2/1993 European Pat. Off.. 75 Inventors: Eleftherios P. Diamandis, Toronto; Russell Redshaw, Nepean, both of OTHER PUBLICATIONS Canada Clinical BioChemistry vol. 27, No. 2, (Yu, He et al), pp. 73 Assignee: Nordion International Inc., Canada 75-79, dated Apr. 27, 1994. Database Biosis BioSciences Information Service, AN 21 Appl. No.: 08/569,206 94:393008 & Journal of Clinical Laboratory Analysis, vol. 8, No. 4, (Yu, He et al), pp. 251-253, dated 1994. 22 PCT Filed: Jul. 14, 1994 Bas. Appl. Histochem, Vol. 33, No. 1, (Papotti, M. et al), 86 PCT No.: PCT/CA94/00392 Pavia pp. 25–29 dated 1989. S371 Date: Apr. 11, 1996 Primary Examiner Yvonne Eyler S 102(e) Date: Apr. 11, 1996 Attorney, Agent, or Firm-Banner & Witcoff, Ltd. 87 PCT Pub. No.: WO95/02424 57 ABSTRACT It was discovered that prostate-specific antigen is produced PCT Pub. Date:Jan. 26, 1995 by non-proStatic endocrine cancers. It was further discov 30 Foreign Application Priority Data ered that non-prostatic endocrine cancers with Steroid recep tors can be stimulated with Steroids to cause them to produce Jul. 14, 1993 GB United Kingdom ................... 93.14623 PSA either initially or at increased levels.
    [Show full text]
  • WO 2018/060501 A2 05 April 2018 (05.04.2018) W ! P O PCT
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2018/060501 A2 05 April 2018 (05.04.2018) W ! P O PCT (51) International Patent Classification: (71) Applicants: MYOVANT SCIENCES GMBH [CH/CH]; A61K 31/513 (2006.01) Viaduktstrasse 8, 405 1 Basel (CH). TAKEDA PHAR¬ MACEUTICAL COMPANY LIMITED [JP/JP]; 1-1, (21) International Application Number: Doshomachi 4-chome, Chuo-ku, Osaka-shi, Osaka, PCT/EP20 17/074907 541-0045 (JP). (22) International Filing Date: (72) Inventors: JOHNSON, Brendan Mark; 2017 Markham 29 September 2017 (29.09.2017) Drive, Chapel Hill, 275 14 (NC). SEELY, Lynn; 537 Occi (25) Filing Language: English dental Avenue, San Mateo, 94402 (US). MUDD, JR., Paul N.; 302 Beacon Falls Court, Cary, North Carolina 27519 (26) Publication Langi English (US). WOLLOWITZ, Susan; 32 Topper Court, Lafayette, (30) Priority Data: California 94549 (US). HIBBERD, Mark; The Old House, 62/402,034 30 September 2016 (30.09.2016) US Hawkley, Liss Hampshire GU33 6NQ (GB). TANIMO- 62/402,055 30 September 2016 (30.09.2016) US TO, Masataka; c/o Takeda Pharmaceutical Company Lim 62/402,150 30 September 2016 (30.09.2016) US ited, 1-1, Doshomachi 4-chome, Chuo-ku, Osaka-shi, O sa 62/492,839 0 1 May 2017 (01 .05.2017) US ka, 541-0045 (JP). RAJASEKHAR, Vijaykumar Reddy; 62/528,409 03 July 2017 (03.07.2017) US 20200 Quail Hollow Road, Apple Valley, California 92308 (54) Title: METHODS OF TREATING UTERINE FIBROIDS AND ENDOMETRIOSIS PBAC=0 Lumbar BMD CD n co CD P g CO O O CD Dose (mg) FIG.
    [Show full text]